Neo-Avagal

Neo-Avagal Brand names, Neo-Avagal Analogs

Neo-Avagal Brand Names Mixture

Biosol-M-Aquadrops liq (methscopolamine bromide + neomycin sulfate)
Neomix-pamine Scour Bolus (methscopolamine bromide + neomycin sulfate)
Neomix-pamine Solution (methscopolamine bromide + neomycin sulfate)
Neosol M Aquadrops (methscopolamine bromide + neomycin)
Scour solution (methscopolamine bromide + neomycin)
Scour solution coop (methscopolamine bromide + neomycin)

Neo-Avagal Chemical_Formula

C₁₈H₂₄NO₄.Br

Neo-Avagal RX_link

http://www.rxlist.com/cgi/pharmclips2.cgi?keyword=%20Methscopolamine

Neo-Avagal fda sheet

Neo-Avagal FDA

Neo-Avagal msds (material safety sheet)

Neo-Avagal Synthesis Reference

No information avaliable

Neo-Avagal Molecular Weight

397.089 g/mol

Neo-Avagal Melting Point

225 ^oC

Neo-Avagal H₂O Solubility

Freely soluble

Neo-Avagal State

Solid

Neo-Avagal LogP

-2.58

Neo-Avagal Dosage Forms

Tablet (2.5mg, 5mg)

Neo-Avagal Indication

Used as adjunctive therapy for the treatment of peptic ulcer. Also used to treat nausea and vomiting due to motion sickness.

Neo-Avagal Pharmacology

Methscopolamine bromide is a muscarinic antagonist structurally similar to the neurotransmitter acetylcholine and acts by blocking the muscarinic acetylcholine receptors and is thus classified as an anticholinergic. Methscopolamine bromide has many uses including the prevention of motion sickness. It is not clear how methscopolamine bromide prevents nausea and vomiting due to motion sickness. The vestibular part of the ear is very important for balance. When a person becomes disoriented due to motion, the vestibule sends a signal through nerves to the vomiting center in the brain, and vomiting occurs. Acetylcholine is a chemical that nerves use to transmit messages to each other. It is believe that methscopolamine bromide prevents communication between the nerves of the vestibule and the vomiting center in the brain by blocking the action of acetylcholine. Methscopolamine bromide also may work directly on the vomiting center. Methscopolamine bromide must be taken before the onset of motion sickness to be effective.

Neo-Avagal Absorption

Poorly and unreliably absorbed, total absorption is 10-25%.

Neo-Avagal side effects and Toxicity

Symptoms of a methscopolamine bromide overdose include headache, nausea, vomiting, dry mouth, difficulty swallowing, blurred vision, dilated pupils, hot, dry skin, dizziness; drowsiness, confusion, anxiety, seizures, weak pulse, and an irregular heartbeat. In addition, a curare-like action may occur, i.e., neuromuscular blockade leading to muscular weakness and possible paralysis.

Neo-Avagal Patient Information